Are National Perox. latest results good or bad?
National Peroxide's latest results are concerning, with a significant decline in Profit Before Tax and Profit After Tax, alongside a 20.86% decrease in net sales year-on-year and an operating profit margin of -3.20%. Overall, the financial metrics indicate ongoing challenges for the company.
National Peroxide has reported its financial results for the quarter ending March 2025, which indicate significant challenges for the company. The Profit Before Tax (PBT) has fallen to Rs -7.82 crore, a notable decline compared to the average PBT of Rs 1.24 crore over the previous four quarters. Similarly, the Profit After Tax (PAT) is reported at Rs -6.49 crore, which is a substantial drop from the average PAT of Rs 1.83 crore in prior quarters.In terms of sales, the net sales for the latest six months reached Rs 135.86 crore, reflecting a year-on-year decrease of 20.86%. The operating profit recorded at Rs -2.36 crore represents the lowest level in the last five quarters, indicating a negative trend in operational efficiency. The operating profit margin also reached a low of -3.20%, further emphasizing the difficulties faced by the company in maintaining profitability. Additionally, the earnings per share (EPS) fell to Rs -11.29, highlighting ongoing challenges in generating shareholder value.
The company saw an adjustment in its evaluation, reflecting the overall decline in key financial metrics. The quarterly results also show a net sales growth of 18.56% compared to the previous quarter, although the standalone net profit experienced a decline of 326.97%. The operating profit margin, at -3.20%, indicates ongoing operational struggles. Overall, the financial data presents a concerning picture for National Peroxide in this reporting period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
